Medicenna Therapeutics Corp (MDNAF)

[2H2]

Big conference next week. Paris.

Oui oui!

[2H2]

Bollies on daily are tightening up kids. Big conference coming up in sept

[2H2]

Research-Capital analyst- $MDNAF buy rating & $4.5 TP

MDNA11 continue to demonstrate compelling efficacy:
2 patients #melanoma & #pancreatic treated with MDNA11 continue to demonstrate a complete response

Notably, both patients were previously treated with checkpoint inhibitors

[2H2]

And more awesome results. 20x bagger here soon? Pc needs a new top line therapy, guess who?

[2H2]

MDNAF is a presenter at ASCO. Huge news!

[2H2]

Great presentation at ASCO

[Monksdream]

It is what they all say about stonks trading on Cromwell Coulson’s stonk market

[2H2]

Relishing soon. This will be 10x current value this year

[Monksdream]

Delisted from Nasdaq
Gee, it sure is great to watch the price of a stock I bought at $400 a share advance to a 52=week high

[2H2]

Getting legs here. Train leaving.

[axelvento]

Cash runway extended through multiple data readouts and into Q1 of calendar 2025

MDNA11 is generally well tolerated and continues to demonstrate encouraging single-agent activity from Phase 1 portion of the ABILITY-1 Study including 100% and 70% reduction of target lesions in pancreatic and melanoma cancer patients, respectively

https://ir.medicenna.com/news-releases/news-release-details/medicenna-therapeutics-reports-second-quarter-fiscal-2024

[Renee]

MDNA changed to MDNAF. Delisted from the Nasdaq to the OTC.

https://otce.finra.org/otce/dailyList?viewType=Additions

[Monksdream]

MDNA new 52 week low

[Monksdream]

MDNA new 52 week low

[Monksdream]

MDNA NEW 52 week low

[Investopotia]

Medicenna Therapeutics $MDNA highlighted in Midas Letter/BioPub interview: Top Stocks to Buy Now? 3 Biotech Stocks for your Watchlist

[EagleD]

Going much higher. Double digits in a few months

[EagleD]

Nice after hours action, Just made 20,000. Yadda Yadda Yadda.

Nobody is here listening to me. THis one is going to be a beast tho

[EagleD]

FDA meeting Tuesday. Seems like we'll know sometime in October the results

[EagleD]

This is my largest holding -- ever. Lots of value to be unveiled here in the coming months.

[Renee]

MDNA moved from the OTC to the Nasdaq:

https://otce.finra.org/otce/dailyList?viewType=Deletions

[tykundegex]

Just stumbled onto this co.. was doing some research. Great interim results in their Phase2b! Encouraging grants in the past, and prestigious medical centers for their trials. I may nibble to create a starting position here.

I can't find any webinars or conf call recordings that the company has given, do you know if any exist?

[BioSpecialist]

Nice move yesterday ..

Small Phase 2b trial has huge chance to be successful because it was already successfull in prior studies so this stock like to be above $10 after phase 2 results in early Q1 . And that Management holding 15+ million shares of the 24.3 million shares outstanding makes me also optimistic .GL


MDNA55 is enrolling patients in a Phase 2b clinical trial for rGB at leading brain cancer centres in the US. MDNA55 has completed 3 clinical trials in 72 patients, including 66 adults with rGB, demonstrated compelling efficacy and obtained Fast-Track and Orphan Drug status from USFDA. Unlike most other cancer therapies, Medicenna's IL4-ECs have the potential to purge both the tumor and the immunosuppressive tumor microenvironment,


Medicenna Phase 2b trial using Brainlab technology
http://www.biotuesdays.com/briefs/2017/6/8/medicenna-phase-2b-trial-using-brainlab-technology

The current Phase 2b clinical trial plans to enroll 43 adult patients with rGB at leading brain cancer centers in the U.S.